ATE258804T1 - Verfahren zur verabreichung von wachstumsfaktoren - Google Patents

Verfahren zur verabreichung von wachstumsfaktoren

Info

Publication number
ATE258804T1
ATE258804T1 AT97938406T AT97938406T ATE258804T1 AT E258804 T1 ATE258804 T1 AT E258804T1 AT 97938406 T AT97938406 T AT 97938406T AT 97938406 T AT97938406 T AT 97938406T AT E258804 T1 ATE258804 T1 AT E258804T1
Authority
AT
Austria
Prior art keywords
administration
growth factors
diffusion
enhanced
growth factor
Prior art date
Application number
AT97938406T
Other languages
English (en)
Inventor
Susan Croll-Kalish
Stefano Peter S Di
Stanley J Wiegand
Ronald M Lindsay
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of ATE258804T1 publication Critical patent/ATE258804T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT97938406T 1996-10-16 1997-08-19 Verfahren zur verabreichung von wachstumsfaktoren ATE258804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2856696P 1996-10-16 1996-10-16
PCT/US1997/014536 WO1998016242A1 (en) 1996-10-16 1997-08-19 Method of enhancing the delivery of growth factors

Publications (1)

Publication Number Publication Date
ATE258804T1 true ATE258804T1 (de) 2004-02-15

Family

ID=21844162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938406T ATE258804T1 (de) 1996-10-16 1997-08-19 Verfahren zur verabreichung von wachstumsfaktoren

Country Status (8)

Country Link
EP (1) EP0938333B1 (de)
JP (1) JP2001502323A (de)
AT (1) ATE258804T1 (de)
AU (1) AU733394B2 (de)
CA (1) CA2269075A1 (de)
DE (1) DE69727491T2 (de)
IL (1) IL129482A0 (de)
WO (1) WO1998016242A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9913457A (pt) * 1998-09-03 2001-10-16 Neuronz Ltd Neuroproteção
FR2793684B1 (fr) * 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US7112570B2 (en) 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
GB0303362D0 (en) * 2003-02-13 2003-03-19 Enact Pharma Plc Tissue regeneration
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
ZA928730B (en) * 1991-11-12 1993-05-10 Regeneron Pharma Therapeutic and diagnostic methods based on tissue-specific NT-3 expression and receptor binding.
JPH08508035A (ja) * 1993-03-19 1996-08-27 イミュネックス・コーポレーション 可溶性レセプターと複合化したリガンドを含む医薬組成物

Also Published As

Publication number Publication date
EP0938333A1 (de) 1999-09-01
EP0938333B1 (de) 2004-02-04
AU733394B2 (en) 2001-05-10
JP2001502323A (ja) 2001-02-20
DE69727491T2 (de) 2004-12-02
IL129482A0 (en) 2000-02-29
WO1998016242A1 (en) 1998-04-23
AU4073797A (en) 1998-05-11
DE69727491D1 (de) 2004-03-11
CA2269075A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
EA200000445A1 (ru) Способы лечения состояния гиперкоагуляции или приобретенной недостаточности белка c
DE69326125D1 (de) System zur Anwendung von Knoten in chirurgischem Nahtmaterial
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
BR9801355B1 (pt) emulsço àleo-em-Água, composiÇço cosmÉtica de uso tàpico, utilizaÇço de uma emulsço, processo de tratamento nço terapÊutico da pele e processo de preparaÇço de uma emulsço.
EP1264604A3 (de) Verbesserungen in oder an Kontrastmitteln
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
ATE135216T1 (de) Verwendung von spiperone-derivate zur immunosuppression
DE3689943D1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
ATE342278T1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE3886254D1 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
ATE362380T1 (de) Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
DE3779281D1 (de) Duenner moertel zur bodeneinspritzung und methode zur anwendung.
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
ATE258804T1 (de) Verfahren zur verabreichung von wachstumsfaktoren
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE69133140D1 (de) 2-Aryl-5-(trifluoromethyl)-2-pyrrolinderivate und Verfahren zur Herstellung von 2-Aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)-pyrrolen mit insektizider Wirkung
ATA901396A (de) Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten
DE3677910D1 (de) Haarwuchspraeparat das vasoaktives darmpolypeptid als aktives mittel enthaelt und verfahren zur anwendung dieses praeparats zum foerdern des haarwuchses.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
KR900017599A (ko) 종양 치료용 약학 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938333

Country of ref document: EP